Sun Pharma Advanced Research Company Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sun Pharma Advanced Research Company Ltd. on BSE

Load latest

Sun Pharma Advanced Research Company Ltd.

17 May 2024

161.43

-0.66%

Board Meeting

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Intimation for Board Meeting For …

BSE India

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 ,inter alia, to consider and approve As attached

pdf

Sun Pharma Advanced Research Company Ltd.

18 Apr 2024

161.43

-0.66%

Earnings Call

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Analyst / Investor …

BSE India

Transcript of the Investor's call on Vodobatinib Parkinson's Disease program held on April 15, 2024

pdf

Sun Pharma Advanced Research Company Ltd.

17 Apr 2024

161.43

-0.66%

Company Update

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Audio Playback Of The Investor Call For …

BSE India

As attached

pdf

Sun Pharma Advanced Research Company Ltd.

12 Apr 2024

161.43

-0.66%

Company Update

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Certificate Under Regulation 40 (9) Of The …

BSE India

As attached

pdf

Sun Pharma Advanced Research Company Ltd.

10 Apr 2024

161.43

-0.66%

Company Update

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Certificate under Reg. 74 (5) of SEBI …

BSE India

As attached

pdf

Sun Pharma Advanced Research Company Ltd.

10 Apr 2024

161.43

-0.66%

Company Update

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliance Certificate - Regulation 7(3) Of SEBI …

BSE India

As attached

pdf

Sun Pharma Advanced Research Company Ltd.

10 Apr 2024

161.43

-0.66%

Company Update

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Press Release / …

BSE India

SPARC Announcement Press Release

pdf

Sun Pharma Advanced Research Company Ltd.

04 Apr 2024

161.43

-0.66%

Corp. Note

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Format of the Initial Disclosure to be …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySUN PHARMA ADVANCED RESEARCH COMPANY LTD. 2CIN NO.L73100GJ2006PLC047837 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ACUITE RATINGS & RESEARCH LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Kajal Damania Designation: Company Secretary and Compliance Officer EmailId: kajal.damania@sparcmail.com Name of the Chief Financial Officer: Chetan Rajpara Designation: Chief Financial officer EmailId: chetan.rajpara@sparcmail.com Date: 04/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf